Monday, February 21, 2022 12:58:41 PM
CytoDyn got similar "helpful advice" from the FDA about allowing their drug "Leronlimab" to save lives by using EINDs. The theory was. It would interfere with trial enrollment.
Thus the life-saving EINDs stopped.
It looks like sales halt at month's end.
Understand, Tollovir potentially threatens the vaccination cash cow! The fewer people aware of Tollovid, its safety and efficacy... the better in BPs squinty little eyes.
Tollovid's availability up to now, has posed a possible problem/distraction/alternate response to Covid-19. This is NOT something bringing joy to BP.
Sorrowfully - Good-bye Tollovid!
IMO
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM